EntryPoint Capital’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

EntryPoint Capital’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-98	Closed	-$6.09K	–	1838
2023 Q4	$6.09K	Buy	+98	New	+$2.44K	0.01%	1203

EntryPoint Capital's RYZB Position: Q1 2024 in Review

EntryPoint Capital sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 98 shares — an estimated $6.09K sold.

EntryPoint Capital first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $6.09K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

EntryPoint Capital reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
EntryPoint Capital sold 98 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $6.09K.
EntryPoint Capital first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
EntryPoint Capital's RayzeBio, Inc. Common Stock position peaked at $6.09K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.